McKesson Corp logo

McKesson Corp MCK

Market Closed
14 Jun, 20:00
NYSE NYSE
$
589. 95
-1.12
-0.19%
After Hours
$
600. 00
+10.05 +1.7%
107.85B Market Cap
17.39 P/E Ratio
2.48% Div Yield
728,200 Volume
25.95 Eps
$ 591.07
Previous Close
Day Range
585.96 592.33
Year Range
389.48 592.41

MCK Chart

McKesson Corp Profile

Medical Distribution Industry
Healthcare Sector
Mr. Brian S. Tyler Ph.D. CEO
NYSE Exchange
US58155Q1031 ISIN
United States Country
45,000 Employees
1 Apr 2024 Last Dividend
5 Jan 1998 Last Split
15 Nov 1994 IPO Date

Overview

McKesson Corporation stands as a prominent provider of healthcare services not only within the United States but also on an international platform. With its foundation laid in 1833, the company has excelled in extending its footprint across various segments of the healthcare industry, making it headquartered in Irving, Texas. Operating through four main segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International, McKesson strives to address the variegated needs of the healthcare realm. These segments collaborate to distribute pharmaceuticals, offer technological and clinical solutions, and ensure necessary medical supplies reach healthcare providers efficiently.

Products and Services

  • U.S. Pharmaceutical:
  • This segment is instrumental in distributing a vast array of pharmaceuticals, including branded, generic, specialty, biosimilar, and over-the-counter drugs. Furthermore, it caters to community-based oncology and other specialty practices by supplying practice management, technology, clinical support, and business solutions. Additionally, it encompasses services like consulting, outsourcing, technological offerings, and providing financial, operational, and clinical solutions targeted at pharmacies.

  • Prescription Technology Solutions (RxTS):
  • Under this banner, McKesson takes a significant step towards bridging the medication-related gaps between biopharma, life sciences partners, and patients by interlinking patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies. The RxTS segment aims at rolling out innovative solutions to streamline the process of medication acquisition, ensuring the delivery of medicine that enriches patient health. Services rendered include prescription price transparency, benefit insight, dispensing support, third-party logistics, and wholesale distribution support.

  • Medical-Surgical Solutions:
  • This segment ensures the streamlined distribution of medical and surgical supplies, logistics, and other pivotal services to various healthcare settings, encompassing physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. It represents McKesson's commitment to providing essential supplies and services that support the health ecosystem's backbone, thereby enabling healthcare providers to deliver quality care.

  • International:
  • McKesson's International segment focuses on the distribution of pharmaceuticals and medical supplies, along with rendering services to a vast customer base, including wholesale, institutional, and retail channels across Europe and Canada. This segment showcases the company's dedication to extending its healthcare services and products to a global audience, ensuring an international footprint in healthcare distribution and services.

Contact Information

Address: 6555 State Highway 161
Phone: 972 446 4800